Q3 2025 Earnings Call October 30, 2025 8:30 AM EDTCompany ParticipantsRalph Giacobbe - Senior Vice President of Investor ...
Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.
Candidates eyeing this role should check the exam syllabus and begin their preparation without any delay. It will help them ...